IMCELL
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
IMCELL - overview
Established
2010
Location
Beijing, -, China
Primary Industry
Healthcare
About
Established in 2010 and based in Beijing, China, IMCELL is a biological skin care service provider. In December 2017, it closed a series A funding from new investor Beijing Guosheng Jingdong Culture Communication. The company's main business is the research and development and sales of biological skin care products, health management, etc. Its main brand is IMCELL.
The company generates revenue by providing stem cell technology development, biological skin care development, sales, cloud health management and other services.
Current Investors
Beijing Guosheng Jingdong Culture Communication
Primary Industry
Healthcare
Sub Industries
Beauty & Hygiene, Healthcare
Website
www.imcell.cn
Verticals
E-commerce
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.